Vanguard Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $236M | Sell |
|
|||||
|
2025
Q2 | $370M | Sell |
|
|||||
|
2025
Q1 | $324M | Sell |
|
|||||
|
2024
Q4 | $404M | Buy |
|
|||||
|
2024
Q3 | $416M | Buy |
|
|||||
|
2024
Q2 | $425M | Sell |
|
|||||
|
2024
Q1 | $461M | Sell |
|
|||||
|
2023
Q4 | $462M | Buy |
|
|||||
|
2023
Q3 | $482M | Buy |
|
|||||
|
2023
Q2 | $456M | Buy |
|
|||||
|
2023
Q1 | $441M | Buy |
|
|||||
|
2022
Q4 | $412M | Buy |
|
|||||
|
2022
Q3 | $385M | Buy |
|
|||||
|
2022
Q2 | $327M | Buy |
|
|||||
|
2022
Q1 | $310M | Buy |
|
|||||
|
2021
Q4 | $259M | Sell |
|
|||||
|
2021
Q3 | $345M | Sell |
|
|||||
|
2021
Q2 | $326M | Buy |
|
|||||
|
2021
Q1 | $542M | Buy |
|
|||||
|
2020
Q4 | $576M | Sell |
|
|||||
|
2020
Q3 | $424M | Sell |
|
|||||
|
2020
Q2 | $475M | Sell |
|
|||||
|
2020
Q1 | $550M | Buy |
|
|||||
|
2019
Q4 | $601M | Sell |
|
|||||
|
2019
Q3 | $662M | Sell |
|
|||||
|
2019
Q2 | $673M | Sell |
|
|||||
|
2019
Q1 | $493M | Buy |
|
|||||
|
2018
Q4 | $562M | Buy |
|
|||||
|
2018
Q3 | $644M | Buy |
|
|||||
|
2018
Q2 | $494M | Sell |
|
|||||
|
2018
Q1 | $413M | Buy |
|
|||||
|
2017
Q4 | $291M | Buy |
|
|||||
|
2017
Q3 | $219M | Buy |
|
|||||
|
2017
Q2 | $187M | Buy |
|
|||||
|
2017
Q1 | $190M | Buy |
|
|||||
|
2016
Q4 | $175M | Buy |
|
|||||
|
2016
Q3 | $152M | Buy |
|
|||||
|
2016
Q2 | $117M | Buy |
|
|||||
|
2016
Q1 | $139M | Buy |
|
|||||
|
2015
Q4 | $124M | Buy |
|
|||||
|
2015
Q3 | $122M | Buy |
|
|||||
|
2015
Q2 | $156M | Buy |
|
|||||
|
2015
Q1 | $164M | Buy |
|
|||||
|
2014
Q4 | $130M | Buy |
|
|||||
|
2014
Q3 | $121M | Sell |
|
|||||
|
2014
Q2 | $122M | Sell |
|
|||||
|
2014
Q1 | $115M | Buy |
|
|||||
|
2013
Q4 | $143M | Buy |
|
|||||
|
2013
Q3 | $127M | Buy |
|
|||||
|
2013
Q2 | $128M | Buy |
|